Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kasper

Showing results (271-280 of 334) with videos related to

Pageof 34
Sort By:
The Journal of Infectious Diseases|September 9, 2000
Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy womenC J Baker, L C Paoletti, M A Rench, et al.
American Journal of Obstetrics and Gynecology|August 15, 1983
Antibody to type III group B Streptococcus in the rhesus monkeyJ W Larsen, J S Harper, W T London, et al.
The Journal of Clinical Investigation|November 15, 1996
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccineD L Kasper, L C Paoletti, M R Wessels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunityW M Kalka-Moll, A O Tzianabos, Y Wang, et al.
The Journal of Infectious Diseases|December 8, 1998
Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and IbC J Baker, L C Paoletti, M R Wessels, et al.
Pediatrics|October 1, 1977
Colonization with group B streptococci in girls under 16 years of ageM R Hammerschlag, C J Baker, S Alpert, et al.
Infection and Immunity|March 16, 2002
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14Hilde-Kari Guttormsen, Carol J Baker, Moon H Nahm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
IL-2 mediates protection against abscess formation in an experimental model of sepsisA O Tzianabos, P R Russell, A B Onderdonk, et al.
The Journal of Biological Chemistry|April 15, 1991
Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharideM R Wessels, J L DiFabio, V J Benedì, et al.
Clinical Immunology (Orlando, Fla.)|November 11, 2008
Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccinationHilde-Kari Guttormsen, Lynda M Stuart, Lei Shi, et al.
Pageof 34

Showing results (271-280 of 334) with videos related to

Sort By:
Pageof 34
The Journal of Infectious Diseases|September 9, 2000
Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy womenC J Baker, L C Paoletti, M A Rench, et al.
American Journal of Obstetrics and Gynecology|August 15, 1983
Antibody to type III group B Streptococcus in the rhesus monkeyJ W Larsen, J S Harper, W T London, et al.
The Journal of Clinical Investigation|November 15, 1996
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccineD L Kasper, L C Paoletti, M R Wessels, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunityW M Kalka-Moll, A O Tzianabos, Y Wang, et al.
The Journal of Infectious Diseases|December 8, 1998
Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and IbC J Baker, L C Paoletti, M R Wessels, et al.
Pediatrics|October 1, 1977
Colonization with group B streptococci in girls under 16 years of ageM R Hammerschlag, C J Baker, S Alpert, et al.
Infection and Immunity|March 16, 2002
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14Hilde-Kari Guttormsen, Carol J Baker, Moon H Nahm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
IL-2 mediates protection against abscess formation in an experimental model of sepsisA O Tzianabos, P R Russell, A B Onderdonk, et al.
The Journal of Biological Chemistry|April 15, 1991
Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharideM R Wessels, J L DiFabio, V J Benedì, et al.
Clinical Immunology (Orlando, Fla.)|November 11, 2008
Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccinationHilde-Kari Guttormsen, Lynda M Stuart, Lei Shi, et al.
Pageof 34